These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36203054)

  • 1. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.
    Leng L; Yuan Z; Pan R; Su X; Wang H; Xue J; Zhuang K; Gao J; Chen Z; Lin H; Xie W; Li H; Chen Z; Ren K; Zhang X; Wang W; Jin ZB; Wu S; Wang X; Yuan Z; Xu H; Chow HM; Zhang J
    Nat Metab; 2022 Oct; 4(10):1287-1305. PubMed ID: 36203054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease.
    Fairley LH; Lai KO; Wong JH; Chong WJ; Vincent AS; D'Agostino G; Wu X; Naik RR; Jayaraman A; Langley SR; Ruedl C; Barron AM
    Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2209177120. PubMed ID: 36787364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer's progression.
    Codocedo JF; Mera-Reina C; Bor-Chian Lin P; Fallen PB; Puntambekar SS; Casali BT; Jury-Garfe N; Martinez P; Lasagna-Reeves CA; Landreth GE
    Cell Rep; 2024 Jul; 43(7):114488. PubMed ID: 39002124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression.
    Ma Y; Bao J; Zhao X; Shen H; Lv J; Ma S; Zhang X; Li Z; Wang S; Wang Q; Ji J
    Mol Cell Proteomics; 2013 Oct; 12(10):2833-44. PubMed ID: 23816988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk.
    D Bruce K; Tang M; Reigan P; H Eckel R
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial amyloid beta clearance is driven by PIEZO1 channels.
    Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
    J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual roles of hexokinase 2 in shaping microglial function by gating glycolytic flux and mitochondrial activity.
    Hu Y; Cao K; Wang F; Wu W; Mai W; Qiu L; Luo Y; Ge WP; Sun B; Shi L; Zhu J; Zhang J; Wu Z; Xie Y; Duan S; Gao Z
    Nat Metab; 2022 Dec; 4(12):1756-1774. PubMed ID: 36536134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in
    Shin JH; Hwang YS; Jung BK; Seo SH; Ham DW; Shin EH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
    Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
    FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation.
    Yang S; Du Y; Zhao X; Tang Q; Su W; Hu Y; Yu P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.
    Codocedo JF; Mera-Reina C; Lin PB; Puntambekar SS; Casali BT; Jury N; Martinez P; Lasagna-Reeves CA; Landreth GE
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology.
    Ren X; Yao L; Wang Y; Mei L; Xiong WC
    J Neuroinflammation; 2022 Mar; 19(1):61. PubMed ID: 35236374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
    Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
    Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice.
    Zhang SS; Zhu L; Peng Y; Zhang L; Chao FL; Jiang L; Xiao Q; Liang X; Tang J; Yang H; He Q; Guo YJ; Zhou CN; Tang Y
    J Neuroinflammation; 2022 Feb; 19(1):34. PubMed ID: 35123512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.